A Novel Model System to Identify Cellular and Molecular Defects Underlying Rare Genetic Disorders
Experimental Dermatology · 2026-03 · 35 (3)
DOI: 10.1111/exd.70238 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Dermatology, online erschienen am 07.03.2026. Verfasst von Maddison N Salois und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA. Hauptthemen laut MEDLINE: Keratinocytes, Ectodermal Dysplasia, Tumor Suppressor Proteins, Cleft Palate. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAMS NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
Ankyloblepharon‐ectodermal defects‐cleft lip/palate (AEC) is a disorder caused by autosomal‐dominant mutations in the TP63 gene. AEC is characterised by the presence of severe and painful skin erosions that can take years to heal. Current treatment options for these devastating lesions are limited, highlighting the need for new therapeutic strategies. We previously generated keratinocytes from patient‐derived induced pluripotent stem cells (iPSC‐K) and identified defects in several cell adhesion complexes, including desmosomes, hemidesmosomes and focal adhesions. In the present study, we developed a complementary in vitro model using NTERT keratinocytes transduced with lentiviral constructs expressing AEC‐related TP63 mutations (N‐AEC). This model allows for the large‐scale production of disease‐relevant material, overcoming the limitations of iPSC‐derived keratinocytes, which have the characteristics of primary keratinocytes, including limited cell doublings and lifespan. We demonstrate that N‐AEC keratinocytes exhibit key defects observed in AEC iPSC‐K and AEC patient skin, including downregulation of cell adhesion proteins. In addition, 3D epidermal equivalents generated from these cells replicate pathological features seen in AEC patient skin, such as intra‐epidermal cysts, reduced desmosomal protein expression and altered expression of differentiation markers. Our N‐AEC model provides a valuable tool for investigating the mechanisms underlying skin fragility in AEC and other genetic skin disorders and advances the potential for novel therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA.
ORCID-Profile: Maddison N Salois
Förderung
- NIAMS NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Salois, M. N., Webb, S., Proctor, I. A., Koch, P. J., & Koster, M. I. (2026). A Novel Model System to Identify Cellular and Molecular Defects Underlying Rare Genetic Disorders. Experimental Dermatology, 35(3). https://doi.org/10.1111/exd.70238
Vancouver
Salois MN, Webb S, Proctor IA, Koch PJ, Koster MI. A Novel Model System to Identify Cellular and Molecular Defects Underlying Rare Genetic Disorders. Experimental Dermatology. 2026;35(3). doi:10.1111/exd.70238
BibTeX
@article{Salois2026,
author = {Salois, Maddison N and Webb, Saiphone and Proctor, Isaiah A and Koch, Peter J and Koster, Maranke I},
title = {A Novel Model System to Identify Cellular and Molecular Defects Underlying Rare Genetic Disorders},
journal = {Experimental Dermatology},
year = {2026},
volume = {35},
number = {3},
doi = {10.1111/exd.70238}
}
EUVIMED